Current State of Cell Therapies for Breast Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference108 articles.
1. Cancer statistics, 2020;CA Cancer J Clin,2020
2. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?;Br J Cancer,2015
3. How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials;J Clin Oncol,2011
4. Breast cancer statistics, 2019;CA Cancer J Clin,2019
5. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study;Sci Rep,2017
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current status and perspectives of clinical trials for tumor-infiltrating lymphocyte therapy;Clinical and Translational Oncology;2024-07-30
2. Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development;Molecular Aspects of Medicine;2024-02
3. Resistance to Immunotherapy in Breast Cancer;Overcoming Breast Cancer Therapy Resistance;2024
4. Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors;Hematology/Oncology Clinics of North America;2023-12
5. Anti-PD-L1 × anti-CD3 bispecific T-cell engager-armed T cells can overcome immunosuppression and redirect T cells to kill breast cancer cells expressing PD-L1;International Immunopharmacology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3